Donor's age dependent proliferation decrease of human bone marrow mesenchymal stem cells is linked to diminished...

Area of Science:

• Regenerative Medicine
• Cell Biology
• Gerontology

Background:

• Mesenchymal stem cells (MSCs) are a promising source for regenerative medicine.
• Their clinical application, especially in the elderly, requires further investigation.
• Donor age is a critical factor influencing MSC properties.

Purpose of the Study:

• To investigate the impact of donor age on the proliferation capacity of human bone marrow-derived MSCs.
• To analyze age-related changes in MSC doubling time, clonogenicity, and phenotype.

Main Methods:

• Isolation and in vitro culture of MSCs from 17 human bone marrow donors (age range: 3-85 years).
• Assessment of doubling time, clonogenicity assays, and immunophenotypic analysis.
• Statistical analysis to correlate age with proliferation parameters.

Main Results:

• Increased doubling time observed in MSCs from older donors compared to younger donors.
• Significant decrease in clonogenicity with increasing donor age.
• No significant changes in MSC phenotype were detected across different age groups.

Conclusions:

• Donor age negatively affects the proliferation capacity and clonogenicity of bone marrow MSCs.
• Age-related decline in MSC function presents challenges for regenerative medicine in elderly populations.
• Further research into the underlying molecular mechanisms is needed to optimize MSC clinical use.